Hyaluronic acid (HA) hydrogels display a wide variety of biomedical applications ranging
from tissue engineering to drug vehiculization and controlled release. To date, most of the …

Background: Endothelial progenitor cells (EPCs) have been well-studied for their
differentiation potential and paracrine activity in vitro and in experimental animal studies …

In this study, an injectable and self-healing hydrogel based on the boronic ester dynamic
covalent bond between phenylboronic acid modified hyaluronic acid (HA-PBA) and the …

Stroke patients with diabetes have worse neurological outcomes than non‐diabetic stroke
patients, and treatments beneficial for non‐diabetic stroke patients are not necessarily …

The use of injectable biomaterials for cell delivery is a rapidly expanding field which may
revolutionize the medical treatments by making them less invasive. However, creating …

Cardiovascular diseases (CVDs), including a series of pathological disorders, severely
affect millions of people all over the world. To address this issue, several potential therapies …

Cardiovascular diseases are the leading cause of death today and a significant public
health problem. Currently, there is no proper treatment for major cardiovascular diseases …

Stem cells and progenitor cells have been identified as potential new therapeutic options for
severe limb ischemia to induce angiogenesis, and hyaluronic acid (HA) is commonly …

Cell therapy has the potential to regenerate cardiac tissue and treat a variety of cardiac
diseases which are currently without effective treatment. This novel approach to treatment …

Effective therapies for cardiac repair and regeneration after myocardial infarction (MI) are
rather limited. Although microRNAs (miRs) are known to play an important role in improving …